Author:
Cheng Ning,Rahman Md. Motiur,Alatawi Yasser,Qian Jingjing,Peissig Peggy L.,Berg Richard L.,Page C. David,Hansen Richard A.
Funder
U.S. Food and Drug Administration
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference50 articles.
1. World Health Organization. America’s State of Mind Report 2011 [cited 2017 Feb 09].
http://apps.who.int/medicinedocs/en/d/Js19032en/
.
2. BBC. Research. Therapeutic Drugs for Central Nervous System (CNS) Disorders: Technologies and Global Markets 2010 [cited 2017 Feb 09].
http://www.bccresearch.com/market-research/pharmaceuticals/drugs-central-nervous-system-disorders-phm068a.html
.
3. Fischer MA, Avorn J. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit. Pharmacoepidemiol Drug Saf. 2004;13(4):207–14.
4. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997–2000. Ann Intern Med. 2005;142(11):891–7.
5. Express Scripts. Drug Trend Report 2016 [cited 2017 Feb 09].
https://lab.express-scripts.com/lab/drug-trend-report
.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献